Zurich Cantonal Bank
AMPH icon

Zurich Cantonal Bank’s Amphastar Pharmaceuticals AMPH Stock Holding History

Zurich Cantonal Bank’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,504
Closed -$201K – 2598
2025
Q4 		$201K Buy
+7,504
New +$193K ﹤0.01% 2222

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Zurich Cantonal Bank's AMPH Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Amphastar Pharmaceuticals (AMPH) in Q1 2026: 7,783 shares worth $152K. The stake represents ﹤0.01% of the portfolio and ranks #2305 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in AMPH as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in AMPH in Q3 2015 and has held it in 42 quarters since. The position peaked at $667K in Q4 2023. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Zurich Cantonal Bank held 7,783 shares of Amphastar Pharmaceuticals worth $152K as of Q1 2026.
  • Amphastar Pharmaceuticals was a new Zurich Cantonal Bank position in Q1 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2305 holding.
  • Zurich Cantonal Bank first reported a position in Amphastar Pharmaceuticals in Q3 2015 and has held it in 42 quarters since.
  • Zurich Cantonal Bank's Amphastar Pharmaceuticals position peaked at $667K in Q4 2023.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.